Chen Li‡
a,
Haixia Ge‡a,
Bing Yinab,
Mengyao Shea,
Ping Liu*a,
Xiangdong Lia and
Jianli Li*a
aCollege of Chemistry & Materials Science, Northwest University, Xi'an 710069, P. R. China. E-mail: lijianli@nwu.edu.cn; liuping@nwu.edu.cn
bCollege of Chemistry, Beijing Normal University, Beijing 100875, P. R. China
First published on 14th January 2015
18 unprecedented tetrazines unsymmetrically substituted at C3 and C6 by an aromatic heterocycle have been successfully prepared by the S-induced reaction of aromatic nitriles with hydrazine hydrate under thermal conditions. The spectral property investigation suggests that compounds 4d, 4e, 4f, 4p, 4q, 4r, and 4v can display intense fluorescence in the visible region, and their fluorescent properties are affected by the substituents both in tetrazine and in phenyl rings. Moreover, the electrochemical behaviors of these synthesized tetrazines are demonstrated to be fully reversible. Furthermore, density functional theory (DFT) calculations for these compounds were performed to investigate their optimized structures, Fukui function and reactivity or selectivity in the inverse electron demand Diels–Alder reaction.
The 1,2,4,5-tetrazine ring system, which consists of an electron-deficient aromatic heterocycle with four nitrogens, is known for its high colour, biological activity and electrical property. And this system can be applied to biocompatible labelling agents,4 sensors,5 on/off fluorescence switching,6 live cell imaging,7 and components in photovoltaic cells.8 Additionally, the 1,2,4,5-tetrazines typically have high positive enthalpies of formation and high densities, which are suitable for the development of energetic materials with desirable properties, such as explosive, propellant and pyrotechnics.9,10
As the good electron acceptors, 1,2,4,5-tetrazine derivatives can be used as 4-π components in inverse-type Diels–Alder reactions,11 and provide an access to many heterocycles12 and natural products.13 Furthermore, 1,2,4,5-tetrazine derivatives exhibit various biological activities such as antibacterial, antiviral and antitumor properties,2,14,15 therefore these compounds can served as pesticides, herbicides and anti-inflammatory, antimalarial drugs (Fig. 1).16–19
Among many reported 1,2,4,5-tetrazine derivatives,20 the 3,6-symmetrically disubstituted ones are common due to their synthetic accessibility.1b,13,21 In contrast, the reported 3,6-unsymmetrically disubstituted-1,2,4,5-tetrazines are limited, and especially their substituents at C3 and C6 positions are usually the alkyl and some specific substituent groups (methylthio, methoxycarbonyl and methylsulfinyl).11a,21,22 Furthermore, 3,6-unsymmetrically disubstituted-1,2,4,5-tetrazines with the aromatic heterocyclic substituents at C3 and C6 have rarely been reported. In addition, it is known that the substituents have an important effect on biological activities and chemical/physical properties of compounds. For 3,6-unsymmetrically disubstituted-1,2,4,5-tetrazines, the aromatic heterocyclic substituents at C3 and C6 will have the more significant effect on their spectral and electrochemical properties. Therefore, such 1,2,4,5-tetrazine derivatives may be served as potential materials with special properties. Based on this aim, we have devoted our recent efforts to the design and synthesis of new 3,6-unsymmetrically disubstituted-1,2,4,5-tetrazines, and the investigation of their application potential.
Herein, we detailed S-induced one-pot synthesis method for target compounds, and 18 novel 3,6-unsymmetrically disubstituted-1,2,4,5-tetrazines were first reported (Scheme 1). Moreover, the spectral and electrochemical properties23 of obtained compounds were examined. And a systematic theoretical investigation based on the density functional theory (DFT)24 calculation were carried out. Amazingly, these 1,2,4,5-tetrazines with the aromatic heterocyclic substituents at C3 and C6 positions not only can serve as special materials having both optical and electrochemical features, but also show the good reactivity or selectivity in the inverse-type Diels–Alder reaction.
![]() | ||
| Scheme 1 Preparation of 3,6-unsymmetrically disubstituted-1,2,4,5-tetrazines from nitriles and hydrazine hydrate. | ||
| Entry | T (°C) | Sulfur (equiv.) | t [h] | Yieldb (%) |
|---|---|---|---|---|
| a Reaction condition: 1a, 2a (each 1.0 equivalent, 0.5 mmol), hydrazine hydrate 3 (10.0 equivalents, 5.0 mmol), ethanol solution (3.0 mL), sulfur (4.0 equivalents, 2.0 mmol) at 78 °C.b Isolated product yields. | ||||
| 1 | rt | 0.05 | 9 | 17 |
| 2 | 78 | 0.05 | 9 | 20 |
| 3 | 78 | 0.1 | 9 | 27 |
| 4 | 78 | 1 | 9 | 34 |
| 5 | 78 | 2 | 9 | 59 |
| 6 | 78 | 4 | 9 | 72 |
| 7 | 78 | 4 | 5 | 55 |
| 8 | 78 | 4 | 7 | 63 |
| 9 | 78 | 4 | 10 | 76 |
| 10 | 78 | 4 | 12 | 80 |
| 11 | 78 | 4 | 14 | 81 |
| 12 | 78 | 0 | 12 | 0 |
| 13 | 58 | 4 | 12 | 64 |
| 14 | 68 | 4 | 12 | 73 |
| 15 | 88 | 4 | 12 | 79 |
Under the optimized condition, additional aromatic nitriles were examined to expand the substrate scope, and the results are summarized in Table 2. To our delight, the reaction of various nitriles, such as cyanopyridine and substituted benzonitrile, with 3 underwent smoothly in excellent yields.
On the basis of the related literature,3a a tentative mechanism for the S-induced reaction between nitriles and hydrazine hydrate, which synthesizes 3,6-unsymmetrically disubstituted-1,2,4,5-tetrazine derivatives via addition–elimination–rearrangement, was proposed in Scheme 2. To inducing the reaction, the S is involved in the reaction process by reacting with hydrazine hydrate to form NH2NHSH.3a The possible structure of NH2NHSH was calculated at DFT level using double-ζ basis set (6-31G** for H element, 6-31+G* for S, N elements). Then, the NH2NHSH interacts with nitrile to produce the key intermediate [1], and this result is supported by the Fukui function f(r)− calculation. The f(r)− calculation result shows that the nitrogen atom connecting with SH of the NH2NHSH should be the first choice for the nitrile electrophilic attack since its value of condensed Fukui function (0.144) is larger than those of other atoms. The 3D representation of Fukui function f(r)− of NH2NHSH and the condensed f(r)− values of N atoms of NH2NHSH are shown in Scheme 2. The intermediate [1] further reacts with the other nitrile to generate [2]. Then, the [2] might be activated by eliminating of hydrogen sulfide to form intermediate [3]. Subsequently, the intermediate [3] converts to the [4] by electrocyclic rearrangement. Finally, the intermediate [4] converts to the target product by air oxidation. In the process of reaction, symmetrical products are also generated, but their yields are very low. The result may be arise from the fact that the concentration of R1-CN is much lower than that of R2-CN after the intermediate [1] is produced. Then [1] more easily reacts with the nitrile with a higher concentration to form the unsymmetrical product. Thus the yield of the unsymmetrical product is much higher than that of the symmetrical product. Moreover, with a kind of nitrile as the substrate, the major product is the symmetrical tetrazines.
![]() | ||
| Scheme 2 A tentative S-induced mechanism for synthesis of 3,6-unsymmetrically disubstituted-1,2,4,5-tetrazine derivatives. | ||
![]() | ||
| Fig. 2 UV-vis absorbance spectra of the compounds 4d, 4e, 4f, 4p, 4q, 4r, 4u, and 4v in dichloromethane (c = 1 × 10−6 mol L−1). | ||
![]() | ||
| Fig. 3 Fluorescence spectra of the compounds 4d, 4e, 4f, 4p, 4q, 4r, 4u, and 4v in dichloromethane (c = 1 × 10−6 mol L−1). | ||
| Entry | λexc, max | λemi, maxa | Φub |
|---|---|---|---|
| a The fluorescence spectra of compounds 4d, 4e, 4f, 4p, 4q, 4r, 4u, and 4v in dichloromethane (c = 1 × 10−6 mol L−1). The excitation slit width is 1.5 nm, the emission slit width is 3 nm.b Fluorescence quantum yield was determined by using quinine sulfate as a standard with Φ = 0.55 in 0.05 mol L−1 H2SO4. | |||
| 4d | 335 | 407 | 0.54 |
| 4e | 335 | 405 | 0.35 |
| 4f | 335 | 418 | 0.67 |
| 4u | 335 | 396 | 0.10 |
| 4p | 344 | 430 | 0.22 |
| 4q | 344 | 441 | 0.58 |
| 4r | 344 | 443 | 0.37 |
| 4v | 344 | 408 | 0.43 |
According to the phenyl substituent at C3, the eight compounds can be divided into two series: (1) 4u, 4d, 4e, 4f (–OCH3 series) and (2) 4v, 4p, 4q, 4r (–NH2 series). Comparison of fluorescence data of the 4u (4-CH3OC6H4) and 4v (4-NH2C6H4) show that the fluorescent wavelength of the latter is longer, since the amino group possesses stronger electron-donating ability resulting in bigger π-conjugation. Then, we compared the fluorescence data of –OCH3 series 4u, 4d, 4e, 4f, and it is found that the fluorescent wavelengths of 4d, 4e and 4f are longer than that of 4u. Interestingly, this same situation exists for –NH2 series compounds 4v, 4p, 4q and 4r. Furthermore, the observed change trends of fluorescent wavelengths of two series of compounds are 4f > 4d > 4e > 4u and 4r > 4q > 4p > 4v, respectively. This result could be explained by the intramolecular charge transfer (ICT). For 4d, 4e, 4f and 4p, 4q, 4r, the whole molecule could form ICT from strong electron-donating groups (4-XC6H4, X = OCH3, NH2) in C3 position to electron-withdrawing group (strong electron-withdrawing group –C5H5N (pyridyl) or weaker electron-withdrawing groups (4-XC6H4, X = CH3 Cl, Br)) in the C6 position, and thus the degree of π-conjugation is increased and the fluorescent wavelengths of these compounds are longer than those of 4u and 4v, respectively. The above results reveal that the substituents in tetrazine and in phenyl rings both have the important effects on the fluorescence of these compounds. More importantly, the fluorescence of these compounds are in the visible range, suggesting their good application potential as the photoelectricity functional material and in photocatalyst technology.
![]() | ||
| Fig. 4 Cyclic voltammetry (CV) curves for compounds 4a–v, the obtained samples in 2 M KOH electrolyte versus SCE at scan rate of 20 mV s−1, the voltage window was ranged from 0.0–0.5 V. | ||
Moreover, it is found that all the investigated tetrazines can exhibit very high reduction potentials, and the electron-rich or -poor group in the heterocyclic substituent can cause a slightly shift of the redox potential. For the reversible system, the equation as follows:
![]() | (1a) |
| E1/2 = (Epa + Epc)/2 | (1b) |
| Entry | Epa | Epc | ΔEp | E1/2 | n |
|---|---|---|---|---|---|
| a Epa represents the oxidation potential; Epc represents the reduction potential; ΔEp is the potential difference between Epa and Epc; E1/2 is the half-wave potential; n is the number of electron transferred. | |||||
| 4a | 0.357 | 0.265 | 0.092 | 0.311 | 0.64 |
| 4b | 0.332 | 0.236 | 0.097 | 0.284 | 0.61 |
| 4c | 0.347 | 0.258 | 0.089 | 0.303 | 0.66 |
| 4d | 0.389 | 0.309 | 0.080 | 0.349 | 0.74 |
| 4e | 0.330 | 0.235 | 0.094 | 0.283 | 0.63 |
| 4f | 0.396 | 0.314 | 0.082 | 0.355 | 0.72 |
| 4g | 0.352 | 0.261 | 0.091 | 0.307 | 0.65 |
| 4h | 0.340 | 0.270 | 0.070 | 0.305 | 0.84 |
| 4i | 0.349 | 0.260 | 0.089 | 0.305 | 0.66 |
| 4j | 0.383 | 0.294 | 0.089 | 0.316 | 0.66 |
| 4k | 0.328 | 0.240 | 0.088 | 0.284 | 0.67 |
| 4l | 0.384 | 0.302 | 0.082 | 0.343 | 0.72 |
| 4m | 0.369 | 0.307 | 0.062 | 0.338 | 0.95 |
| 4n | 0.327 | 0.240 | 0.087 | 0.284 | 0.68 |
| 4o | 0.393 | 0.304 | 0.089 | 0.349 | 0.66 |
| 4p | 0.370 | 0.260 | 0.110 | 0.315 | 0.54 |
| 4q | 0.327 | 0.263 | 0.064 | 0.295 | 0.92 |
| 4r | 0.355 | 0.260 | 0.095 | 0.306 | 0.62 |
| 4s | 0.343 | 0.243 | 0.100 | 0.293 | 0.59 |
| 4t | 0.350 | 0.265 | 0.085 | 0.308 | 0.69 |
| 4u | 0.352 | 0.261 | 0.091 | 0.307 | 0.65 |
| 4v | 0.355 | 0.263 | 0.092 | 0.309 | 0.64 |
We systematically performed calculations for all the synthesized tetrazine derivatives 4a–v. The geometry optimization of 4a was based on its X-ray crystal structure (Fig. 5), and the others were based on the molecular structures drawn by Chem3D and Gaussview.
To investigate the site reactivity concerning nucleophilic attack or site selectivity, the calculation of Fukui function f(r)+ for synthesized tetrazines was carried out.28 The equation of Fukui function f(r)+ as follows:
![]() | (2a) |
| f(r)+ = qxN+1 − qxN | (2b) |
For 4a, the 3D representation of the Fukui function and the condensed Fukui function of atoms are shown in Fig. 6 (4b–v, see in the ESI†). The 3D representation of f(r)+ clearly demonstrates that the region around the N atoms of the 1,2,4,5-tetrazine skeleton possess higher reactivity than other parts. Therefore the 1,2,4,5-tetrazine skeleton as the electron-deficient unit may has the stronger electrophilic ability, and can be used as the 4-π components in the inverse-type Diels–Alder reaction. Furthermore, the f(r)+ calculation results also indicate the regioselectivity in the inverse-type Diels–Alder reaction.
![]() | ||
| Fig. 6 3D representation of the Fukui function f(r)+ (positive in red color and negative in green color) and the condensed Fukui function f(r)+ of related atoms of 4a. | ||
The frontier orbitals HOMO and LUMO for all the synthesized tetrazine derivatives have been also calculated. The 3D representations of HOMO and LUMO orbitals of 4a are shown in Fig. 7 (the shapes of HOMO and LUMO orbitals of 4b–v are shown in the ESI†). The energies of HOMO, LUMO, and the LUMO–HOMO gap for 4a–v are depicted in Table 5.
| Entry | EHOMO | ELUMO | ΔEL–H |
|---|---|---|---|
| a EHOMO, ELUMO, ΔEL–H represent the energies of HOMO, LUMO, and the LUMO–HOMO gap, respectively. | |||
| 4a | −6.265 | −2.746 | 3.52 |
| 4b | −6.455 | −2.980 | 3.48 |
| 4c | −6.569 | −3.063 | 3.51 |
| 4d | −6.208 | −2.691 | 3.52 |
| 4e | −6.299 | −2.926 | 3.37 |
| 4f | −6.406 | −3.004 | 3.40 |
| 4g | −6.643 | −3.131 | 3.51 |
| 4h | −6.832 | −3.356 | 3.48 |
| 4i | −6.957 | −3.445 | 3.51 |
| 4j | −6.491 | −2.978 | 3.51 |
| 4k | −6.681 | −3.205 | 3.48 |
| 4l | −6.800 | −3.290 | 3.51 |
| 4m | −6.501 | −2.988 | 3.51 |
| 4n | −6.691 | −3.214 | 3.48 |
| 4o | −6.810 | −3.299 | 3.51 |
| 4p | −5.717 | −2.545 | 3.17 |
| 4q | −5.876 | −2.752 | 3.12 |
| 4r | −5.882 | −2.762 | 3.12 |
| 4s | −6.723 | −3.271 | 3.45 |
| 4t | −6.973 | −3.453 | 3.52 |
| 4u | −5.881 | −2.618 | 3.26 |
| 4v | −5.435 | −2.404 | 3.03 |
![]() |
−6.324 | −2.832 | 3.49 |
![]() |
−8.154 | −4.519 | 3.64 |
![]() |
−6.630 | −3.095 | 3.54 |
![]() |
−6.337 | −2.803 | 3.53 |
The inverse-type Diels–Alder reactions between 1,2,4,5-tetrazines and electron-rich dienes depends on the LUMOdiene–HOMOdienophile gap.29 Thus for these 1,2,4,5-tetrazine derivatives as the electron-deficient dienophile, elevating their HOMO energies can facilitate the reaction. We compared the energies of HOMO, LUMO, and the LUMO–HOMO gap for 4a–v, the result reveals that using NH2, CH3O, and CH3 as substituent can increase the HOMO energies in comparison to the CN and CF3, that is to say, the electron-donating substituents will increase the HOMO energies of these compounds. Moreover, we investigated the frontier molecular orbitals (FMOs) of previously reported 3,6-disubstituted-1,2,4,5-tetrazines, which have the good reactivity in the inverse-type Diels–Alder reaction.11d,11f,34 The HOMO energies of our tetrazine derivatives are comparable to those of the reported tetrazine derivatives, and some of them even have the higher HOMO energies than the reported ones (Table 5). Therefore, almost all of the compounds (4a–v) have the good potential of participating in the inverse-type Diels–Alder reaction.
:
1, Rf = 0.26); purple solid (99.6 mg, 80% yield); mp: 178–181 °C; 1H NMR (400 MHz, CDCl3) δ 8.97 (d, J = 3.4 Hz, 1H), 8.70 (d, J = 7.9 Hz, 1H), 8.60 (d, J = 8.0 Hz, 2H), 8.00 (t, J = 7.1 Hz, 1H), 7.62–7.53 (m, 1H), 7.44 (d, J = 7.9 Hz, 2H), 2.50 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ 164.6, 163.5, 151.1, 150.6, 144.1, 137.7, 130.4, 129.0, 128.6, 126.5, 124.0, 22.0 ppm; IR (KBr) νmax/cm−1 1605, 1580, 1393, 1245, 1177, 1116, 919, 812; HRMS (ESI) m/z: [M + Na]+ calcd for C14H11N5 + Na+ 250.1093; found: 250.1093.
:
1, Rf = 0.40); purple solid (100.9 mg, 81%); mp: 197–199 °C; 1H NMR (400 MHz, CDCl3) δ 9.85 (s, 1H), 8.88 (dd, J = 6.6, 5.3 Hz, 2H), 8.54 (dd, J = 8.2, 5.3 Hz, 2H), 7.77 (d, J = 8.5 Hz, 1H), 7.55–7.59 (m, 1H), 7.43 (d, J = 8.0 Hz, 1H), 2.49 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ 164.6, 162.9, 153.3, 149.4, 144.2, 135.1, 130.4, 128.9, 128.4, 128.2, 124.2, 22.0 ppm; IR (KBr) νmax/cm−1 2361, 1604, 1583, 1393, 1178, 1107, 1017, 917, 849, 817, 593; HRMS (ESI) m/z: [M + Na]+ calcd for C14H11N5 + Na+ 250.1093; found: 250.1093.
:
1, Rf = 0.39); purple solid (103.4 mg, 83%), mp: 231–233 °C; 1H NMR (400 MHz, CDCl3) δ 8.92 (d, J = 5.9 Hz, 2H), 8.56 (d, J = 8.2 Hz, 2H), 8.47 (d, J = 6.0 Hz, 2H), 7.43 (d, J = 8.1 Hz, 2H), 2.50 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ 164.6, 162.6, 151.0, 144.2, 139.2, 130.2, 128.4, 128.3, 121.0, 21.7 ppm; IR(KBr) νmax/cm−1 2914, 1604, 1595, 1393, 1212, 1179, 1054, 921, 828, 598; HRMS (ESI) m/z: [M + Na]+ calcd for C14H11N5 + Na+ 250.1093; found: 250.1093.
:
1, Rf = 0.18); white solid (106.0 mg, 80%); mp: >270 °C; 1H NMR (400 MHz, CDCl3) δ 8.70 (d, J = 4.4 Hz, 1H), 8.41 (d, J = 8.0 Hz, 1H), 7.99 (d, J = 8.5 Hz, 2H), 7.88 (t, J = 7.7 Hz, 1H), 7.40 (dd, J = 12.4, 6.4 Hz, 1H), 7.02 (d, J = 8.4 Hz, 2H), 3.89 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ 172.2, 150.3, 150.1, 149.7, 137.4, 129.9, 125.7, 121.3, 121.2, 114.9, 100.3, 55.8 ppm; IR(KBr) νmax/cm−1 1606, 1517, 1437, 1408, 1307, 1249, 1173, 1115, 1029, 985, 828, 601; HRMS (ESI) m/z: [M + Na]+ calcd for C14H11N5O + Na+ 288.0861; found: 288.0827.
:
1, Rf = 0.23); white solid (107.4 mg, 81%); mp: 158–159 °C; 1H NMR (400 MHz, CDCl3) δ 9.17 (s, 1H), 8.73 (d, J = 4.2 Hz, 1H), 8.37 (d, J = 7.9 Hz, 1H), 7.97 (d, J = 8.7 Hz, 2H), 7.46 (dd, J = 7.8, 4.9 Hz, 1H), 7.02 (d, J = 8.7 Hz, 2H), 3.89 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ 168.4, 163.7, 162.0, 151.4, 148.6, 134.5, 129.5, 126.5, 123.8, 122.2, 114.5, 55.3 ppm; IR (KBr) νmax/cm−1 1607, 1571, 1403, 1250, 1178, 1026, 835, 705.
:
1, Rf = 0.22); white solid (104.7 mg, 79%); mp: 164–165 °C; 1H NMR (400 MHz, CDCl3) δ 8.77 (d, J = 5.0 Hz, 2H), 7.97 (d, J = 8.6 Hz, 2H), 7.86 (d, J = 5.0 Hz, 2H), 7.02 (d, J = 8.6 Hz, 2H), 3.89 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ 169.1, 164.6, 162.1, 150.6, 137.1, 129.5, 122.1, 121.3, 114.5, 55.4 ppm; IR(KBr) νmax/cm−1 1598, 1400, 1313, 1179, 824, 698; HRMS (ESI) m/z: [M + H]+ calcd for C14H11N5O + H+ 266.1042; found: 266.1049.
:
1, Rf = 0.25); purple solid (115.2 mg, 76%); 1H NMR (400 MHz, CDCl3) δ 9.00 (d, J = 4.2 Hz, 1H), 8.84 (d, J = 8.0 Hz, 2H), 8.73 (d, J = 7.8 Hz, 1H), 8.03 (t, J = 7.7 Hz, 1H), 7.90 (d, J = 8.0 Hz, 2H), 7.60 (t, 1H) ppm; 13C NMR (100 MHz, CDCl3) δ 163.6, 163.4, 150.9, 149.8, 137.4, 134.7, 134.5, 128.5, 126.5, 126.2, 126.1, 124.1 ppm; IR(KBr) νmax/cm−1 1581, 1398, 1327, 1156, 1113, 1067, 910, 825; HRMS (ESI) m/z: [M + H]+ calcd for C14H8F3N5 + H+ 304.0810; found: 304.0809.
:
1, Rf = 0.29); purple solid (113.7 mg, 75%); 1H NMR (400 MHz, CDCl3) δ 9.89 (s, J = 1.6 Hz, 1H), 8.93 (dq, J = 4.8, 1.6 Hz, 2H), 8.81 (d, J = 8.2 Hz, 2H), 7.91 (d, J = 8.3 Hz, 2H), 7.60 (dd, J = 7.9, 4.9 Hz, 1H) ppm; 13C NMR (100 MHz, CDCl3) δ 187.6, 163.5, 163.2, 153.5, 149.4, 135.2, 134.7, 128.4, 127.5, 126.3, 126.3, 124.0 ppm; IR(KBr) νmax/cm−1 1587, 1517, 1394, 1321, 1193, 1162, 1114, 1067, 909, 863, 830; HRMS (ESI) m/z: [M + H]+ calcd for C14H8F3N5 + H+ 304.0810; found: 304.0817.
:
1, Rf = 0.28); purple solid (118.2 mg, 78%); 1H NMR (400 MHz, CDCl3) δ 8.96 (d, J = 4.5 Hz, 2H), 8.83 (d, J = 8.1 Hz, 2H), 8.51 (d, J = 4.5 Hz, 2H), 7.92 (d, J = 8.2 Hz, 2H) ppm; 13C NMR (100 MHz, CDCl3) δ 163.8, 163.2, 151.2, 138.8, 134.8, 134.5, 128.6, 126.4, 126.4, 121.3 ppm; IR(KBr) νmax/cm−1 1633, 1400, 1325, 1170, 1132, 1067, 1108, 918, 841; HRMS (ESI) m/z: [M + H]+ calcd for C14H8F3N5 + H+ 304.0810; found: 304.0805.
:
1, Rf = 0.27); purple solid (99.5 mg, 74%); mp: 218–219 °C; 1H NMR (400 MHz, CDCl3) δ 8.98 (d, J = 4.6 Hz, 1H), 8.70 (d, J = 7.9 Hz, 1H), 8.66 (d, J = 8.5 Hz, 2H), 8.01 (t, J = 7.7 Hz, 1H), 7.66–7.55 (m, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ 164.0, 163.7, 151.2, 150.4, 139.9, 137.7, 130.2, 130.0, 129.9, 126.7, 124.2 ppm; IR(KBr) νmax/cm−1 2361, 1633, 1588, 1394, 1118, 1085, 913, 813; HRMS (ESI) m/z: [M + H]+ calcd for C13H8ClN5 + H+ 270.0546; found: 270.0544.
:
1, Rf = 0.28); purple solid (100.9 mg, 75%); mp: 217–219 °C; 1H NMR (400 MHz, CDCl3) δ 9.86 (s, 1H), 8.90 (t, J = 6.8 Hz, 2H), 8.63 (d, J = 8.5 Hz, 2H), 7.57–7.63 (m, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ 163.9, 163.1, 153.5, 149.5, 139.9, 135.3, 130.1, 130.0, 129.6, 127.9, 124.2 ppm; IR(KBr) νmax/cm−1 1638, 1589, 1407, 1172, 1098, 912, 820; HRMS (ESI) m/z: [M + H]+ calcd for C13H8ClN5 + H+ 270.0546; found: 270.0547.
:
1, Rf = 0.28); purple solid (98.2 mg, 73%); mp: 242–243 °C; 1H NMR (400 MHz, CDCl3) δ 8.94 (d, J = 4.5 Hz, 2H), 8.64 (d, J = 8.0 Hz, 2H), 8.49 (d, J = 4.5 Hz, 2H), 7.63 (d, J = 8.1 Hz, 2H) ppm; 13C NMR (100 MHz, CDCl3) δ 164.49, 163.36, 151.60, 140.41, 139.41, 130.28, 130.00, 121.58, 100.38 ppm; IR(KBr) νmax/cm−1 1635, 1592, 1400, 1170, 1091, 1007, 915, 830; HRMS (ESI) m/z: [M + H]+ calcd for C13H8ClN5 + H+ 270.0546; found: 270.0544.
:
1, Rf = 0.28); purple solid (117.4 mg, 75%); mp: 191–193 °C; 1H NMR (400 MHz, CDCl3) δ 8.98 (d, J = 4.3 Hz, 1H), 8.70 (d, J = 7.9 Hz, 1H), 8.57 (d, J = 8.3 Hz, 2H), 8.01 (t, J = 7.7 Hz, 1H), 7.77 (d, J = 8.3 Hz, 2H), 7.58 (dd, J = 7.4, 4.8 Hz, 1H) ppm; 13C NMR (100 MHz, CDCl3) δ 164.1, 163.7, 151.2, 150.3, 137.7, 132.9, 130.6, 129.9, 128.5, 126.7, 124.2 ppm; IR(KBr) νmax/cm−1 1584, 1393, 1116, 1066, 913, 862, 588; HRMS (ESI) m/z: [M + H]+ calcd for C13H8BrN5 + H+ 314.0041; found: 314.0029.
:
1, Rf = 0.27); purple solid (112.7 mg, 72%); mp: 229–231 °C; 1H NMR (400 MHz, CDCl3) δ 9.87 (s, 1H), 8.89–8.92 (m, 2H), 8.55 (d, J = 8.6 Hz, 2H), 7.79 (d, J = 8.6 Hz, 2H), 7.58 (dd, J = 7.9, 4.9 Hz, 1H) ppm; 13C NMR (100 MHz, CDCl3) δ 164.0, 163.1, 153.4, 149.4, 135.1, 132.8, 130.4, 129.6, 128.4, 127.8, 124.1 ppm; IR(KBr) νmax/cm−1 1635, 1588, 1400, 1109, 914, 820, 590; HRMS (ESI) m/z: [M + H]+ calcd for C13H8BrN5 + H+ 314.0041; found: 314.0036.
:
1, Rf = 0.28); purple solid (115.8 mg, 74%); mp: 244–247 °C; 1H NMR (400 MHz, CDCl3) δ 8.95 (d, J = 5.8 Hz, 2H), 8.57 (d, J = 8.6 Hz, 2H), 8.50 (d, J = 5.9 Hz, 2H), 7.80 (d, J = 8.6 Hz, 2H) ppm; 13C NMR (100 MHz, CDCl3) δ 164.3, 163.0, 151.2, 139.0, 132.9, 130.2, 129.7, 128.7, 121.2 ppm; IR(KBr) νmax/cm−1 1638, 1584, 1396, 1173, 1106, 1005, 920, 831, 593; HRMS (ESI) m/z: [M + H]+ calcd for C13H8BrN5 + H+ 314.004; found: 314.0048.
:
1, Rf = 0.32); yellow solid (110.5 mg, 85%); mp: 180–181 °C; 1H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 7.8 Hz, 2H), 7.81 (d, J = 8.1 Hz, 2H), 7.28 (d, J = 12.7 Hz, 2H), 6.74 (d, J = 8.1 Hz, 2H), 4.01 (s, 2H), 2.42 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ 168.4, 166.9, 149.4, 141.4, 130.0, 129.6, 127.9, 120.5, 115.1, 21.7 ppm; IR(KBr) νmax/cm−1 3130, 1600, 1516, 1401, 1261, 1098, 1019, 825.
:
1, Rf = 0.31); yellow solid (111.8 mg, 79%); mp: 192–194 °C; 1H NMR (400 MHz, CDCl3) δ 7.93 (d, J = 8.5 Hz, 2H), 7.81 (d, J = 8.5 Hz, 2H), 7.46 (d, J = 8.5 Hz, 2H), 6.74 (d, J = 8.5 Hz, 2H), 4.04 (s, 2H) ppm; 13C NMR (100 MHz, CDCl3) δ 168.7, 165.2, 149.3, 136.7, 129.5, 129.3, 128.9, 128.8, 120.0, 114.8 ppm; IR(KBr) νmax/cm−1 3133, 1629, 1400, 1181, 1089, 821.
:
1, Rf = 0.34); yellow solid (132.4 mg, 81%); mp: 236–238 °C; 1H NMR (400 MHz, CDCl3) δ 7.86 (d, J = 8.2 Hz, 2H), 7.81 (d, J = 8.3 Hz, 2H), 7.62 (d, J = 8.0 Hz, 2H), 6.74 (d, J = 8.1 Hz, 2H), 4.04 (s, 2H) ppm; 13C NMR (100 MHz, DMSO) δ 174.0, 169.0, 157.3, 137.5, 134.3, 134.3, 134.2, 129.3, 121.4, 118.8 ppm; IR(KBr) νmax/cm−1 3131, 1627, 1521, 1401, 1178, 1129, 986, 823.
:
20, Rf = 0.40); purple solid (96.8 mg, 82%); mp: 203–204 °C; 1H NMR (400 MHz, CDCl3) δ 9.86 (s, 2H), 8.90 (t, J = 6.6 Hz, 4H), 7.57 (dd, J = 7.8, 5.0 Hz, 2H) ppm; 13C NMR (100 MHz, CDCl3) δ 163.6, 153.7, 149.6, 135.4, 127.8, 124.3 ppm; IR(KBr) νmax/cm−1 1584, 1387, 1126, 1016, 917, 821, 704, 598.
:
20, Rf = 0.40); purple solid (98.0 mg, 83%); mp: >200 °C; 1H NMR (400 MHz, CDCl3) δ 8.97 (d, J = 4.9 Hz, 4H), 8.53 (d, J = 4.9 Hz, 4H) ppm; 13C NMR (100 MHz, CDCl3) δ 163.7, 151.3, 138.6, 121.4 ppm; IR(KBr) νmax/cm−1 2361, 1588, 1557, 1411, 1389, 1261, 1110, 1053, 921, 831, 715, 600.
:
1, Rf = 0.27); white solid (113.2 mg, 77%); mp: 170–171 °C; 1H NMR (400 MHz, CDCl3) δ 7.93 (d, J = 8.8 Hz, 4H), 7.00 (d, J = 8.8 Hz, 4H), 3.88 (s, 6H) ppm; 13C NMR (100 MHz, CDCl3) δ 167.0, 161.7, 129.3, 122.9, 114.4, 55.4 ppm; IR(KBr) νmax/cm−1 2361, 1608, 1401, 1250, 1173, 987, 828.
:
1, Rf = 0.20); yellow solid (93.8 mg, 71%); mp: >280 °C; 1H NMR (400 MHz, DMSO) δ 7.62 (d, J = 7.4 Hz, 4H), 6.66 (d, J = 7.5 Hz, 4H), 5.82 (s, 4H) ppm; 13C NMR (100 MHz, DMSO) δ 171.2, 156.7, 133.9, 122.1, 118.8 ppm; IR(KBr) νmax/cm−1 3126, 1627, 1903, 1400, 1307, 1178, 831, 776.
Footnotes |
| † Electronic supplementary information (ESI) available. CCDC 973196. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c4ra10808f |
| ‡ The authors Chen Li and Haixia Ge contributed equally to this work. |
| This journal is © The Royal Society of Chemistry 2015 |